These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9817471)

  • 1. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Perrone-Filardi P; Bacharach SL; Bonow RO
    Am J Cardiol; 1998 Nov; 82(9):1001-7. PubMed ID: 9817471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO
    Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium.
    Dilsizian V; Freedman NM; Bacharach SL; Perrone-Filardi P; Bonow RO
    Circulation; 1992 Feb; 85(2):627-34. PubMed ID: 1735157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
    Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
    Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Freedman NM; Perrone-Filardi P; Bacharach SL; Bonow RO
    Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.
    Nicolai E; Cuocolo A; Acampa W; Varrone A; Pace L; Salvatore M
    J Nucl Cardiol; 1999; 6(3):270-7. PubMed ID: 10385182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium 201 for assessment of myocardial viability.
    Bonow RO; Dilsizian V
    Semin Nucl Med; 1991 Jul; 21(3):230-41. PubMed ID: 1948113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.
    Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA
    J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease.
    Galassi AR; Centamore G; Fiscella A; Coppola A; Liberti F; Franco M; Palazzo G; Musumeci S; Galassi A
    Am J Cardiol; 1995 Mar; 75(7):436-42. PubMed ID: 7863985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function.
    Cuocolo A; Rubini G; Acampa W; Nicolai E; Florimonte L; DiGiovine G; D'Addabbo A; Salvatore M
    J Nucl Cardiol; 2000; 7(3):235-41. PubMed ID: 10888394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
    Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction.
    Panza JA; Dilsizian V; Laurienzo JM; Curiel RV; Katsiyiannis PT
    Circulation; 1995 Feb; 91(4):990-8. PubMed ID: 7850986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium?
    Dilsizian V; Smeltzer WR; Freedman NM; Dextras R; Bonow RO
    Circulation; 1991 Apr; 83(4):1247-55. PubMed ID: 2013145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection.
    Dilsizian V; Bonow RO
    Circulation; 1992 Mar; 85(3):1032-8. PubMed ID: 1537101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.